Aside from financing rounds, new companies, startups and business, we receive countless “smaller” reports every day, which we want to give a platform to here in our ticker in the future. Regardless of whether it is personnel news, project announcements or news and highlights from the industry: we summarize the day chronologically below.
The article is continually updated.
13:50 OpenAI overcomes GPT-4 sluggishness with Turbo update
OpenAI has announced an update to GPT-4 Turbo that is intended to improve code generation and task completion, according to a blog post. The company responded to user complaints about ChatGPT’s sluggishness. OpenAI is planning further updates in the coming months, including the general availability of GPT-4 Turbo with image processing to enable multimodal prompts.
13:40 Biomay announces approval for CRISPR/Cas9-based therapy
The Austrian biotech company Biomay has successfully received approval for the world‘s first CRISPR/Cas9-based therapy. The US and British drug agencies granted marketing approval, while the European gave a positive opinion for the therapy called “Exagamglogene Autotemcel” for treatment. The innovative therapy aims to cure life-threatening genetic diseases and marks “a significant advance” in gene editing.
13:20 Polestar reduces staff by 15 percent
The Swedish electric car maker Polestar plans to cut 15 percent of its jobs worldwide. This corresponds to 450 jobs. The action was taken due to “challenging market conditions,” the company announced on Friday. Polestar had already cut its delivery forecasts and presented a new business plan in November. Polestar had already announced in May 2023 that it would cut ten percent of its jobs and at the same time reduce its production target.
Trending Today: ÖkoFEN 🔹 Traffic emissions